Showing results (331-340 of 950) with videos related to
Sort By:
Pageof 95
Vaccine|June 15, 2004
CEL-1000--a peptide with adjuvant activity for Th1 immune responsesYupin Charoenvit, Neena Goel, Michael Whelan, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 10, 2019
Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleedingLawrence B Afrin, Tania T Dempsey, Lila S Rosenthal, et al.Pharmacological Reviews|October 19, 2021
Parkinson Disease: Translating Insights from Molecular Mechanisms to NeuroprotectionSheila K Pirooznia, Liana S Rosenthal, Valina L Dawson, et al.The American Journal of Pathology|October 1, 1974
Separation and characterization of human neutrophil granulesB C West, A S Rosenthal, N A Gelb, et al.Cancer Research|May 8, 1999
Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cellsC M Simbulan-Rosenthal, D S Rosenthal, R Luo, et al.American Journal of Clinical Pathology|January 1, 1994
Marrow cellularity as a predictor of adequate cell yield for transplantationN S Rosenthal, D C Farhi, R M Fox, et al.Annals of Surgery|January 1, 1978
Splenectomy in myeloid metaplasiaE B Cabot, M F Brennan, D S Rosenthal, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1979
Immune response gene control of determinant selection. II. Genetic control of the murine T lymphocyte proliferative response to insulinL J Rosenwasser, M A Barcinski, R H Schwartz, et al.Acta Virologica|May 1, 1990
Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infectionC Platzer, H Siakkou, J Sober, et al.The Journal of Clinical Psychiatry|April 1, 1984
Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatientsB J Goldstein, B Brauzer, D Kentsmith, et al.Pageof 95